Chelariu-Raicu, A; Trillsch, F; Harter, P; Strobl, R; Sehouli, J; Wimberger, P; Bronger, H; Catherine, S; Lefeuvre, C; Rau, J; Hanker, L; Edgar, P; Heitz, F; Marme, F; El-Balat, A; Stockler, M; de Gregorio, N; Glasspool, R; Mahner, S; Lortholary, A; Pfisterer, J.
Bevacizumab after prior anti-angiogenic Treatment in Female Patients with platinum-based Chemotherapy in Second-line Treatment of recurrent Ovarian Cancer - A Subgroup Analysis of Efficacy and Safety in AGOOVAR 2.21
GEBURTSH FRAUENHEILK. 2024; 84(6): E44-E45.
Doi: 10.1055/s-0044-1787414
[Poster]
Web of Science
FullText
FullText_MUG